BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 25793736)

  • 1. Aberrant expression of PHLPP1 and PHLPP2 correlates with poor prognosis in patients with hypopharyngeal squamous cell carcinoma.
    Zhou J; Yu X; Wang J; Li T; Jin T; Lei D; Pan X
    PLoS One; 2015; 10(3):e0119405. PubMed ID: 25793736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleckstrin Homology Domain Leucine-rich Repeat Protein Phosphatase Acts as a Tumor Suppressor in Oral Squamous Cell Carcinoma.
    Etemad-Moghadam S; Mohammadpour H; Emami Razavi A; Alaeddini M
    Appl Immunohistochem Mol Morphol; 2024 May-Jun 01; 32(5):249-253. PubMed ID: 38602289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the PHLPPside: Emerging roles of PHLPP phosphatases in the heart.
    Lemoine KA; Fassas JM; Ohannesian SH; Purcell NH
    Cell Signal; 2021 Oct; 86():110097. PubMed ID: 34320369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mislocalization of the E3 ligase, β-transducin repeat-containing protein 1 (β-TrCP1), in glioblastoma uncouples negative feedback between the pleckstrin homology domain leucine-rich repeat protein phosphatase 1 (PHLPP1) and Akt.
    Warfel NA; Niederst M; Stevens MW; Brennan PM; Frame MC; Newton AC
    J Biol Chem; 2011 Jun; 286(22):19777-88. PubMed ID: 21454620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of PHLPP1/2 phosphatases rescues pancreatic β-cells in diabetes.
    Lupse B; Annamalai K; Ibrahim H; Kaur S; Geravandi S; Sarma B; Pal A; Awal S; Joshi A; Rafizadeh S; Madduri MK; Khazaei M; Liu H; Yuan T; He W; Gorrepati KDD; Azizi Z; Qi Q; Ye K; Oberholzer J; Maedler K; Ardestani A
    Cell Rep; 2021 Aug; 36(5):109490. PubMed ID: 34348155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of PHLPP2 correlates with clinicopathologic characteristics and prognosis in colorectal cancer.
    Wu SH; Xu XY; Sun CB; Wen FF; He S; Gao XQ; Liu YH; Liu L
    Int J Clin Exp Pathol; 2019; 12(8):2909-2919. PubMed ID: 31934127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PHLPP2 stabilization by p27 mediates its inhibition of bladder cancer invasion by promoting autophagic degradation of MMP2 protein.
    Peng M; Wang J; Zhang D; Jin H; Li J; Wu XR; Huang C
    Oncogene; 2018 Oct; 37(43):5735-5748. PubMed ID: 29930380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revealing molecular and cellular heterogeneity in hypopharyngeal carcinogenesis through single-cell RNA and TCR/BCR sequencing.
    Tie CW; Zhu JQ; Yu Z; Dou LZ; Wang ML; Wang GQ; Ni XG
    Front Immunol; 2024; 15():1310376. PubMed ID: 38720887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PHLPP1 counter-regulates STAT1-mediated inflammatory signaling.
    Cohen Katsenelson K; Stender JD; Kawashima AT; Lordén G; Uchiyama S; Nizet V; Glass CK; Newton AC
    Elife; 2019 Aug; 8():. PubMed ID: 31408005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CPT1A mediates chemoresistance in human hypopharyngeal squamous cell carcinoma via ATG16L1-dependent cellular autophagy.
    Sun L; Wang X; Chen L; Gao Z; Xu S; Hu C; Fan G; Wang B; Feng T; Wang W; Ying X
    Cell Insight; 2023 Dec; 2(6):100127. PubMed ID: 37961047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell transcriptomic landscape and the microenvironment of normal adjacent tissues in hypopharyngeal carcinoma.
    Guan R; Li C; Gu F; Li W; Wei D; Cao S; Chang F; Lei D
    BMC Genomics; 2024 May; 25(1):489. PubMed ID: 38760729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolutionary analysis of PHLPP1 gene in humans and non-human primates.
    Anbazhagan P; Purushottam M; Kumar HB; Kubendran S; Mukherjee O; Brahmachari SK; Jain S; Sowdhamini R
    Bioinformation; 2008 Aug; 2(10):471-4. PubMed ID: 18841245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of PPARG in Chemosensitivity-Regulating Network for Hypopharyngeal Squamous Cell Carcinoma.
    Kong F; Han B; Chen J; Shen X; Hou L; Fang J; Lian M
    PPAR Res; 2023; 2023():6019318. PubMed ID: 37791141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of PHLPP2/cyclin D1 protein translation contributes to the tumor suppressive effect of NFκB2 (p100).
    Xu J; Wang Y; Hua X; Xu J; Tian Z; Jin H; Li J; Wu XR; Huang C
    Oncotarget; 2016 Jun; 7(23):34112-30. PubMed ID: 27095572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription factor C/EBP-β induces tumor-suppressor phosphatase PHLPP2 through repression of the miR-17-92 cluster in differentiating AML cells.
    Yan Y; Hanse EA; Stedman K; Benson JM; Lowman XH; Subramanian S; Kelekar A
    Cell Death Differ; 2016 Jul; 23(7):1232-42. PubMed ID: 26868909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PHLPP2 Downregulation Contributes to Lung Carcinogenesis Following B[a]P/B[a]PDE Exposure.
    Huang H; Pan X; Jin H; Li Y; Zhang L; Yang C; Liu P; Liu Y; Chen L; Li J; Zhu J; Zeng X; Fu K; Chen G; Gao J; Huang C
    Clin Cancer Res; 2015 Aug; 21(16):3783-93. PubMed ID: 25977341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein phosphatase PHLPP induces cell apoptosis and exerts anticancer activity by inhibiting Survivin phosphorylation and nuclear export in gallbladder cancer.
    Qiu Y; Li X; Yi B; Zheng J; Peng Z; Zhang Z; Wu M; Shen F; Su C
    Oncotarget; 2015 Aug; 6(22):19148-62. PubMed ID: 25895131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-3127 promotes cell proliferation and tumorigenicity in hepatocellular carcinoma by disrupting of PI3K/AKT negative regulation.
    Jiang J; Zhang Y; Guo Y; Yu C; Chen M; Li Z; Tian S; Sun C
    Oncotarget; 2015 Mar; 6(8):6359-72. PubMed ID: 25849943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-93 promotes cell proliferation in gliomas through activation of PI3K/Akt signaling pathway.
    Jiang L; Wang C; Lei F; Zhang L; Zhang X; Liu A; Wu G; Zhu J; Song L
    Oncotarget; 2015 Apr; 6(10):8286-99. PubMed ID: 25823655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of PHLPP induced by endoplasmic reticulum stress promotes eIF2α phosphorylation and chemoresistance in colon cancer.
    Guo B; Xiong X; Hasani S; Wen YA; Li AT; Martinez R; Skaggs AT; Gao T
    Cell Death Dis; 2021 Oct; 12(11):960. PubMed ID: 34663797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.